Speech-Language Pathologists in West Peoria, IL Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Kelly Ryon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2302 W Melrose Pl, West Peoria, IL 61604 Phone: 815-212-9995 |
News Archive
Standard Register first quarter total revenues decline 4% to $157.6M
Standard Register today announced its financial results for the first quarter 2012. The Company reported revenue of $157.6 million and a net loss of $5.1 million, or $0.18 per share. The results compare to prior year revenue of $164.9 million and net income of $0.4 million, or $0.01 per diluted share.
Center For Diagnostic Imaging's new center in Avon offers interventional procedures for joint and back pain
Center for Diagnostic Imaging is pleased to announce the opening of an outpatient medical imaging and image-guided procedure center in Avon, Indiana. The new center allows CDI to better serve medical providers and patients in the western Indianapolis communities.
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination
New research from a team of scientists in Australia finds that the second ‘booster' dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). The results suggest one dose of the vaccine was sufficient in providing a robust immune response 11 days after inoculation.
U.N. General Assembly votes to create U.N. agency for women
After three years of negotiations, the U.N. General Assembly unanimously voted on Monday "to create a new, more powerful agency for women, in a move supporters hailed as a breakthrough for women's equality and rights," Reuters reports (Worsnip, 9/14). Last week, Cuba, Egypt, Iran and Sudan "mounted a last-minute campaign to delay ratification" (Kaiser Daily Global Health Policy Report, 9/11).
Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
› Verified 8 days ago